cDC1 vaccines drive tumor rejection by direct presentation independently of host cDC1.
Sign Up to like & getrecommendations! Published in 2022 at "Cancer immunology research"
DOI: 10.1158/2326-6066.cir-21-0865
Abstract: As a cell-based cancer vaccine, dendritic cells (DCs), derived from peripheral blood monocytes or bone marrow (BM) treated with GM-CSF (GMDCs), were initially thought to induce antitumor immunity by presenting tumor antigens directly to host… read more here.
Keywords: anti tumor; cdc1; host cdc1; tumor ... See more keywords